Analyst Ratings for Leap Therapeutics (LPTX)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/29/2025 | H.C. Wainwright » Updated 3/27/2025 |
Swayampakula Ramakanth | Downgrade | Neutral (Buy) |
N/A (N/A) |
0.65 (2.06) |
216.92% | Details |
| 1/28/2025 | Baird | Joel Beatty | Downgrade | Neutral (Outperform) |
1.25 (9.00) |
2.25 (2.06) |
-8.44% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


